Format

Send to

Choose Destination
Lancet Oncol. 2017 Dec;18(12):1568-1569. doi: 10.1016/S1470-2045(17)30844-6. Epub 2017 Nov 13.

Extended adjuvant therapy in patients with HER2-positive breast cancer: some answers, even more questions.

Author information

1
Departments of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA; Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
2
Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Electronic address: eamitten@mdanderson.org.
PMID:
29146400
DOI:
10.1016/S1470-2045(17)30844-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center